LGALS3 and chronic kidney disease: Subgroup analysis showed that OSA patients with CKD had significantly increased LGALS3 protein expression levels than those without CKD (10.67±3.51 versus 6.4±3.44 ng/ml, adjusted p = 0.012, Fig 4G).